| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.67 | 0.016 | 0.67 | Analgesic | 0.506 0.048 DBMET00001 | ||
| 0.592 | 0.01 | 0.592 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.251 0.078 DBMET01583 0.502 0.019 DBMET00001 | ||
| 0.475 | 0.033 | 0.475 | GABA C receptor rho-3 antagonist | 0.444 0.044 DBMET01583 0.475 0.033 DBMET00001 | ||
| 0.495 | 0.082 | 0.527 | Alpha-glucosidase inhibitor | 0.527 0.073 DBMET00001 | DBMET00001 | |
| 0.499 | 0.088 | 0.499 | Antiinflammatory | 0.468 0.102 DBMET00001 | ||
| 0.386 | 0.015 | 0.386 | Non-steroidal antiinflammatory agent | 0.195 0.075 DBMET00001 | ||
| 0.382 | 0.025 | 0.382 | Insulysin inhibitor | 0.291 0.064 DBMET01583 0.38 0.026 DBMET00001 | ||
| 0.402 | 0.056 | 0.475 | Thioredoxin glutathione reductase inhibitor | 0.475 0.034 DBMET00001 | DBMET00001 | |
| 0.425 | 0.08 | 0.485 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.464 0.053 DBMET01583 0.485 0.041 DBMET00001 | DBMET00001 | |
| 0.435 | 0.09 | 0.478 | Beta lactamase inhibitor | 0.478 0.079 DBMET00001 | DBMET00001 | |
| 0.317 | 0.01 | 0.317 | Toll-Like receptor 9 antagonist | 0.113 0.094 DBMET01583 0.295 0.014 DBMET00001 | ||
| 0.365 | 0.068 | 0.365 | Thyroid hormone antagonist | 0.358 0.071 DBMET00001 | ||
| 0.355 | 0.067 | 0.355 | Thyroid hormone beta antagonist | 0.349 0.069 DBMET00001 | ||
| 0.302 | 0.021 | 0.302 | Lipocortins synthesis antagonist | 0.282 0.025 DBMET01583 | ||
| 0.288 | 0.014 | 0.298 | NADPH oxidase inhibitor | 0.298 0.013 DBMET01583 0.134 0.067 DBMET00001 | DBMET01583 | |
| 0.283 | 0.017 | 0.283 | Histone acetyltransferase inhibitor | 0.19 0.084 DBMET01583 0.277 0.018 DBMET00001 | ||
| 0.373 | 0.121 | 0.41 | Transcription factor inhibitor | 0.41 0.106 DBMET00001 | DBMET00001 | |
| 0.257 | 0.03 | 0.257 | Amyloid beta precursor protein antagonist | 0.245 0.035 DBMET00001 | ||
| 0.24 | 0.015 | 0.249 | Ferrochelatase inhibitor | 0.127 0.049 DBMET01583 0.249 0.013 DBMET00001 | DBMET00001 | |
| 0.268 | 0.05 | 0.268 | Anticonvulsant | 0.146 0.134 DBMET00001 | ||
| 0.346 | 0.141 | 0.46 | DNA polymerase beta inhibitor | 0.46 0.098 DBMET00001 | DBMET00001 | |
| 0.328 | 0.134 | 0.385 | Calcium channel L-type activator | 0.385 0.091 DBMET00001 | DBMET00001 | |
| 0.209 | 0.016 | 0.209 | Cyclooxygenase 3 inhibitor | 0.162 0.038 DBMET00001 | ||
| 0.281 | 0.091 | 0.281 | 12-Lipoxygenase inhibitor | 0.18 0.173 DBMET01583 0.265 0.101 DBMET00001 | ||
| 0.331 | 0.149 | 0.395 | MAP kinase 1 inhibitor | 0.3 0.18 DBMET01583 0.395 0.109 DBMET00001 | DBMET00001 | |
| 0.307 | 0.127 | 0.402 | 15-Lipoxygenase inhibitor | 0.32 0.118 DBMET01583 0.402 0.074 DBMET00001 | DBMET00001 | |
| 0.248 | 0.081 | 0.258 | Gastrin inhibitor | 0.234 0.099 DBMET01583 0.258 0.071 DBMET00001 | DBMET00001 | |
| 0.195 | 0.033 | 0.208 | Mannose-6-phosphate isomerase inhibitor | 0.208 0.026 DBMET01583 0.136 0.078 DBMET00001 | DBMET01583 | |
| 0.216 | 0.057 | 0.229 | Focal adhesion kinase 2 inhibitor | 0.157 0.12 DBMET01583 0.229 0.049 DBMET00001 | DBMET00001 | |
| 0.201 | 0.042 | 0.201 | Cyclooxygenase inhibitor | 0.142 0.077 DBMET00001 | ||
| 0.31 | 0.157 | 0.412 | DNA directed DNA polymerase inhibitor | 0.412 0.111 DBMET00001 | DBMET00001 | |
| 0.241 | 0.095 | 0.241 | Spasmolytic | |||
| 0.216 | 0.083 | 0.216 | Cyclic AMP phosphodiesterase inhibitor | 0.191 0.101 DBMET01583 | ||
| 0.177 | 0.044 | 0.185 | GABA C receptor rho-2 antagonist | 0.185 0.038 DBMET01583 0.183 0.04 DBMET00001 | DBMET01583 | |
| 0.173 | 0.042 | 0.173 | Toll-Like receptor antagonist | 0.148 0.057 DBMET00001 | ||
| 0.17 | 0.048 | 0.17 | Cyclooxygenase 1 inhibitor | 0.145 0.06 DBMET00001 | ||
| 0.124 | 0.004 | 0.124 | Corticotropin releasing factor 2 receptor antagonist | 0.056 0.055 DBMET01583 0.093 0.009 DBMET00001 | ||
| 0.292 | 0.175 | 0.401 | 5 Hydroxytryptamine release inhibitor | 0.401 0.078 DBMET01583 0.282 0.187 DBMET00001 | DBMET01583 | |
| 0.103 | 0.009 | 0.103 | Glutamate (mGluR7) antagonist | 0.097 0.012 DBMET01583 | ||
| 0.134 | 0.045 | 0.137 | 5 Hydroxytryptamine 3A agonist | 0.137 0.043 DBMET01583 0.128 0.049 DBMET00001 | DBMET01583 | |
| 0.118 | 0.037 | 0.122 | Hepatocyte growth factor antagonist | 0.122 0.034 DBMET00001 | DBMET00001 | |
| 0.116 | 0.044 | 0.116 | Creatine kinase inhibitor | 0.114 0.045 DBMET01583 0.094 0.066 DBMET00001 | ||
| 0.173 | 0.103 | 0.173 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.161 0.124 DBMET01583 | ||
| 0.101 | 0.039 | 0.119 | Bromodomain-containing protein 2 inhibitor | 0.119 0.024 DBMET00001 | DBMET00001 | |
| 0.066 | 0.004 | 0.066 | Corticotropin releasing factor 1 receptor antagonist | |||
| 0.176 | 0.117 | 0.2 | 5 Hydroxytryptamine 3E antagonist | 0.2 0.063 DBMET01583 0.174 0.123 DBMET00001 | DBMET01583 | |
| 0.104 | 0.045 | 0.106 | Phosphodiesterase 6D inhibitor | 0.106 0.042 DBMET00001 | DBMET00001 | |
| 0.137 | 0.087 | 0.137 | Ca2+-transporting ATPase inhibitor | 0.129 0.126 DBMET01583 | ||
| 0.088 | 0.041 | 0.088 | CC chemokine 5 receptor agonist | 0.083 0.053 DBMET01583 | ||
| 0.199 | 0.153 | 0.199 | Hypoxia-inducible factor 1 alpha inhibitor | 0.19 0.164 DBMET01583 | ||
| 0.193 | 0.148 | 0.193 | Tyrosine 3 hydroxylase inhibitor | 0.192 0.151 DBMET01583 0.184 0.166 DBMET00001 | ||
| 0.079 | 0.037 | 0.079 | Orexin receptor 1 antagonist | |||
| 0.14 | 0.1 | 0.14 | Arachidonic acid antagonist | |||
| 0.119 | 0.079 | 0.174 | M17 leucyl aminopeptidase inhibitor | 0.116 0.082 DBMET01583 0.174 0.043 DBMET00001 | DBMET00001 | |
| 0.066 | 0.034 | 0.066 | Glutamate (mGluR1) antagonist | 0.065 0.034 DBMET01583 0.053 0.046 DBMET00001 | ||
| 0.064 | 0.033 | 0.064 | Phosphodiesterase 1A inhibitor | 0.062 0.037 DBMET00001 | ||
| 0.067 | 0.044 | 0.067 | Orexin receptor antagonist | |||
| 0.128 | 0.106 | 0.149 | Cyclin-dependent kinase 8 inhibitor | 0.149 0.08 DBMET01583 0.132 0.101 DBMET00001 | DBMET01583 | |
| 0.071 | 0.05 | 0.071 | Benzodiazepine agonist | |||
| 0.096 | 0.082 | 0.096 | Cystathionine beta-synthase inhibitor | |||
| 0.131 | 0.117 | 0.131 | Heat shock protein 70 antagonist | |||
| 0.041 | 0.029 | 0.044 | Glutamate (mGluR1a) antagonist | 0.044 0.025 DBMET01583 | DBMET01583 | |
| 0.085 | 0.073 | 0.086 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.086 0.071 DBMET01583 | DBMET01583 | |
| 0.028 | 0.017 | 0.028 | Myristoyl transferase inhibitor | |||
| 0.188 | 0.177 | 0.189 | 5 Hydroxytryptamine uptake stimulant | 0.187 0.18 DBMET01583 0.189 0.176 DBMET00001 | DBMET00001 | |
| 0.089 | 0.079 | 0.146 | GABA C receptor rho-1 antagonist | 0.103 0.058 DBMET01583 0.146 0.023 DBMET00001 | DBMET00001 | |
| 0.091 | 0.082 | 0.091 | Glutamate (mGluR7) agonist | |||
| 0.06 | 0.055 | 0.063 | Transcription factor RelA inhibitor | 0.063 0.046 DBMET01583 | DBMET01583 | |
| 0.009 | 0.006 | 0.009 | Corticotropin releasing factor antagonist | |||
| 0.011 | 0.008 | 0.118 | CD80 antagonist | 0.118 0.001 DBMET01583 0.011 0.008 DBMET00001 | DBMET01583 | |
| 0.081 | 0.079 | 0.094 | Prolactin inhibitor | 0.094 0.062 DBMET01583 | DBMET01583 | |
| 0.137 | 0.136 | 0.138 | Neurotensin receptor agonist | 0.138 0.134 DBMET01583 | DBMET01583 | |
| 0.101 | 0.1 | 0.114 | Alpha-N-acetylglucosaminidase inhibitor | 0.114 0.084 DBMET00001 | DBMET00001 | |
| 0.125 | 0.13 | 0.164 | CF transmembrane conductance regulator agonist | 0.164 0.054 DBMET01583 | DBMET01583 | |
| 0.154 | 0.168 | 0.174 | Streptokinase A inhibitor | 0.174 0.151 DBMET01583 | DBMET01583 | |
| 0.167 | 0.185 | 0.309 | Transcription factor STAT3 inhibitor | 0.309 0.049 DBMET00001 | DBMET00001 | |
| 0.036 | 0.058 | 0.047 | Bromodomain-containing protein 3 inhibitor | 0.047 0.038 DBMET00001 | DBMET00001 | |
| 0.083 | 0.105 | 0.091 | Adenylate kinase inhibitor | 0.091 0.085 DBMET01583 | DBMET01583 | |
| 0.169 | 0.19 | 0.273 | Transcription factor STAT inhibitor | 0.273 0.072 DBMET00001 | DBMET00001 | |
| 0.034 | 0.057 | 0.038 | CF transmembrane conductance regulator antagonist | 0.038 0.034 DBMET01583 | DBMET01583 | |
| 0.051 | 0.077 | 0.063 | Aryl hydrocarbon receptor antagonist | 0.063 0.048 DBMET00001 | DBMET00001 | |
| 0.151 | 0.178 | 0.411 | Hypoglycemic | 0.411 0.026 DBMET01583 | DBMET01583 | |
| 0.159 | 0.186 | 0.171 | DNA synthesis inhibitor | 0.171 0.166 DBMET01583 | DBMET01583 | |
| 0.027 | 0.055 | 0.035 | Vascular adhesion protein 1 inhibitor | 0.035 0.034 DBMET01583 | DBMET01583 | |
| 0.019 | 0.048 | 0.033 | Potassium channel small-conductance Ca-activated activator | 0.033 0.02 DBMET00001 | DBMET00001 | |
| 0.151 | 0.182 | 0.256 | MAP-kinase-activated kinase 5 inhibitor | 0.256 0.056 DBMET01583 | DBMET01583 | |
| 0.199 | 0.23 | 0.239 | Antibacterial | 0.239 0.188 DBMET00001 | DBMET00001 | |
| 0.057 | 0.09 | 0.07 | Adenosine A3 receptor antagonist | 0.07 0.058 DBMET00001 | DBMET00001 | |
| 0.062 | 0.1 | 0.071 | GABA B receptor agonist | 0.071 0.064 DBMET01583 | DBMET01583 | |
| 0.061 | 0.1 | 0.124 | Myeloperoxidase inhibitor | 0.124 0.018 DBMET01583 | DBMET01583 | |
| 0.065 | 0.106 | 0.077 | MAP kinase kinase 7 inhibitor | 0.077 0.056 DBMET01583 | DBMET01583 | |
| 0.071 | 0.117 | 0.097 | Protein kinase C zeta inhibitor | 0.097 0.054 DBMET01583 | DBMET01583 | |
| 0.181 | 0.227 | 0.285 | Histamine release inhibitor | 0.285 0.132 DBMET01583 0.283 0.133 DBMET00001 | DBMET01583 | |
| 0.077 | 0.124 | 0.125 | GABA C receptor antagonist | 0.108 0.066 DBMET01583 0.125 0.047 DBMET00001 | DBMET00001 | |
| 0.068 | 0.122 | 0.083 | Hematopoietic | 0.083 0.065 DBMET00001 | DBMET00001 | |
| 0.045 | 0.099 | 0.071 | Protein kinase C beta inhibitor | 0.071 0.046 DBMET01583 | DBMET01583 | |
| 0.111 | 0.167 | 0.128 | MAP kinase 3 inhibitor | 0.128 0.113 DBMET01583 0.128 0.112 DBMET00001 | DBMET00001 | |
| 0.12 | 0.181 | 0.14 | Succinate dehydrogenase inhibitor | 0.14 0.133 DBMET01583 | DBMET01583 | |
| 0.203 | 0.264 | 0.475 | MAP kinase kinase 6 inhibitor | 0.34 0.1 DBMET01583 0.475 0.025 DBMET00001 | DBMET00001 | |
| 0.15 | 0.212 | 0.177 | Nitric-oxide synthase stimulant | 0.177 0.135 DBMET01583 | DBMET01583 | |
| 0.143 | 0.208 | 0.182 | Prostaglandin dehydrogenase inhibitor | 0.182 0.17 DBMET00001 | DBMET00001 | |
| 0.083 | 0.148 | 0.131 | Cathepsin H inhibitor | 0.131 0.063 DBMET01583 | DBMET01583 | |
| 0.145 | 0.21 | 0.184 | Lipoxygenase inhibitor | 0.184 0.158 DBMET01583 | DBMET01583 | |
| 0.016 | 0.083 | 0.042 | Diamine oxidase inhibitor | 0.042 0.021 DBMET01583 | DBMET01583 | |
| 0.071 | 0.139 | 0.138 | Protein kinase C gamma inhibitor | 0.138 0.039 DBMET01583 | DBMET01583 | |
| 0.034 | 0.102 | 0.048 | Phosphodiesterase 7A inhibitor | 0.048 0.046 DBMET00001 | DBMET00001 | |
| 0.029 | 0.101 | 0.077 | GABA A receptor antagonist | 0.077 0.023 DBMET01583 | DBMET01583 | |
| 0.134 | 0.213 | 0.23 | 5 Hydroxytryptamine 1E antagonist | 0.23 0.097 DBMET00001 | DBMET00001 | |
| 0.175 | 0.255 | 0.266 | Calcium channel activator | 0.266 0.128 DBMET00001 | DBMET00001 | |
| 0.041 | 0.121 | 0.074 | Leucine-rich repeat kinase 2 inhibitor | 0.074 0.064 DBMET00001 | DBMET00001 | |
| 0.049 | 0.132 | 0.075 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.075 0.046 DBMET01583 | DBMET01583 | |
| 0.06 | 0.144 | 0.092 | GABA C receptor agonist | 0.092 0.076 DBMET01583 | DBMET01583 | |
| 0.027 | 0.114 | 0.071 | GABA receptor antagonist | 0.071 0.025 DBMET01583 | DBMET01583 | |
| 0.091 | 0.179 | 0.127 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.127 0.118 DBMET01583 | DBMET01583 | |
| 0.105 | 0.198 | 0.145 | Aldehyde oxidase inhibitor | 0.145 0.144 DBMET01583 | DBMET01583 | |
| 0.029 | 0.125 | 0.053 | Cyclin-dependent kinase 6 inhibitor | 0.053 0.05 DBMET01583 | DBMET01583 | |
| 0.137 | 0.234 | 0.181 | RNA-directed DNA polymerase inhibitor | 0.181 0.131 DBMET00001 | DBMET00001 | |
| 0.109 | 0.207 | 0.148 | ATPase inhibitor | 0.148 0.104 DBMET01583 | DBMET01583 | |
| 0.166 | 0.291 | 0.23 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.23 0.096 DBMET01583 | DBMET01583 | |
| 0.085 | 0.218 | 0.139 | Polo-like kinase-3 inhibitor | 0.139 0.098 DBMET00001 | DBMET00001 | |
| 0.07 | 0.205 | 0.187 | Peroxidase inhibitor | 0.187 0.063 DBMET01583 | DBMET01583 | |
| 0.055 | 0.201 | 0.189 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.189 0.055 DBMET01583 | DBMET01583 | |
| 0.075 | 0.232 | 0.138 | Heat shock protein 90 antagonist | 0.138 0.087 DBMET01583 | DBMET01583 | |
| 0.021 | 0.191 | 0.077 | CDC7 inhibitor | 0.077 0.038 DBMET01583 | DBMET01583 | |
| 0.126 | 0.318 | 0.219 | Sodium/bile acid cotransporter inhibitor | 0.219 0.163 DBMET01583 | DBMET01583 | |
| 0.065 | 0.258 | 0.114 | Factor V inhibitor | 0.114 0.045 DBMET01583 | DBMET01583 | |
| 0.057 | 0.255 | 0.122 | CDC-like kinase 3 inhibitor | 0.122 0.04 DBMET01583 | DBMET01583 | |
| 0.065 | 0.263 | 0.128 | Protein kinase (CK1) gamma 3 inhibitor | 0.128 0.116 DBMET01583 | DBMET01583 | |
| 0.045 | 0.262 | 0.125 | Bone formation stimulant | 0.125 0.081 DBMET00001 | DBMET00001 | |
| 0.031 | 0.298 | 0.083 | Protein kinase C mu inhibitor | 0.083 0.077 DBMET01583 | DBMET01583 | |
| 0.134 | 0.414 | 0.296 | MAP kinase kinase 3 inhibitor | 0.216 0.083 DBMET01583 0.296 0.008 DBMET00001 | DBMET00001 | |
| 0.014 | 0.385 | 0.118 | Aurora-A kinase inhibitor | 0.118 0.055 DBMET01583 | DBMET01583 | |
| 0.002 | 0.38 | 0.089 | Egl nine homolog 2 inhibitor | 0.089 0.003 DBMET01583 | DBMET01583 | |
| 0.013 | 0.44 | 0.154 | CDK2/cyclin A inhibitor | 0.154 0.025 DBMET01583 | DBMET01583 | |
| 0.017 | 0.466 | 0.25 | CDC-like kinase 4 inhibitor | 0.25 0.046 DBMET01583 | DBMET01583 | |
| 0.01 | 0.463 | 0.089 | CDK1/cyclin B1 inhibitor | 0.089 0.033 DBMET01583 | DBMET01583 | |
| 0.012 | 0.518 | 0.334 | Clk dual-specificity kinase inhibitor | 0.334 0.031 DBMET01583 | DBMET01583 | |
| 0.008 | 0.53 | 0.206 | Cyclin-dependent kinase 2 inhibitor | 0.206 0.023 DBMET01583 | DBMET01583 | |
| 0.011 | 0.583 | 0.16 | Cyclin-dependent kinase inhibitor | 0.16 0.051 DBMET01583 | DBMET01583 | |
| 0.006 | 0.651 | 0.446 | Glycogen synthase kinase-3 beta inhibitor | 0.446 0.006 DBMET01583 | DBMET01583 | |
| 0.004 | 0.649 | 0.148 | Protocollagen prolyl hydroxylase inhibitor | 0.148 0.004 DBMET01583 | DBMET01583 | |
| 0.006 | 0.667 | 0.491 | Glycogen synthase kinase-3 inhibitor | 0.491 0.005 DBMET01583 | DBMET01583 | |
| 0.015 | 0.777 | 0.144 | CDK3/cyclin E inhibitor | 0.144 0.031 DBMET01583 | DBMET01583 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |